Morpholine → HCID 178461396, compound
Reaction equation
[CH:1]1([N:7]([C@H:29]2[CH2:34][CH2:33][C@H:32]([CH3:35])[CH2:31][CH2:30]2)[C:8](=[O:28])[NH:9][C:10]2[S:11][C:12]([S:15]([N:18](C)[CH2:19][C:20]([N:22]([CH2:25][CH3:26])[CH2:23][CH3:24])=[O:21])(=[O:17])=[O:16])=[CH:13][N:14]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.C1(N([C@H]2CC[C@H](C)CC2)C(=O)NC2SC(S(NCC(O)=O)(=O)=[O:51])=CN=2)CCCCC1.N1CCOCC1>>[N:22]1([C:20](=[O:21])[CH2:19][NH:18][S:15]([C:12]2[S:11][C:10]([NH:9][C:8]([N:7]([CH:1]3[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]3)[C@H:29]3[CH2:30][CH2:31][C@H:32]([CH3:35])[CH2:33][CH2:34]3)=[O:28])=[N:14][CH:13]=2)(=[O:16])=[O:17])[CH2:23][CH2:24][O:51][CH2:26][CH2:25]1Participants
4
Procedure
The title compound was prepared in a similar manner to 2-({2-[3-cyclohexyl-3-(trans-4-methyl-cyclohexyl)-ureido]-thiazole-5-sulfonyl}-methyl-amino)-N,N-diethyl-acetamide using {2-[3-cyclohexyl-3-(trans-4-methyl-cyclohexyl)-ureido]-thiazole-5-sulfonylamino}-acetic acid and morpholine.
Sources & evidence
- ORD record
- ord-ebca356e03e04cb4b4089bb7f27d56ca
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07582769B2
Reaction notes
Loading…